Whitehawk Therapeutics, Inc. (WHWK) shares surged 23.13 percent to $2.59, up $0.48 on Thursday, after Tempus AI announced a multi-year collaboration with the oncology therapeutics company. The partnership will leverage Tempus' proprietary real-world dataset to advance biomarker-driven research and support the development of Whitehawk's antibody drug conjugate pipeline for cancer treatment.The stock traded between $2.53 and $3.77 during the session, compared with a previous close of $2.11 on the Nasdaq. Tra ...